These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 153798)

  • 1. [Evaluation of immunization against influenza with adenovirus containing strains A/Port Chalmers and A/Swine (author's transl)].
    Sivák S; Oravcová V; Sláciková M; Lancová J; Borská K; Milosovicová A; Péci J; Sýkorová M
    Cesk Epidemiol Mikrobiol Imunol; 1978 Nov; 27(6):355-65. PubMed ID: 153798
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subvirion influenza vaccines: a subunit (glycoprotein) trivalent preparation Grippovac SE-AZh for immunization against influenza in children and persons with chronic pathology].
    Chumakov MP; Mel'nikova SK; Kusov IuIu; Kochetkov NK; Derevitskaia VA
    Vestn Akad Med Nauk SSSR; 1983; (12):21-9. PubMed ID: 6666316
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prophylactic effect of live influenza vaccine in a small epidemic of influenza and its evaluation method (author's transl)].
    Nakamura K; Okuno Y
    Uirusu; 1973 Oct; 23(3):185-95. PubMed ID: 4808056
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenza 2010-2011 in one South Carolina community: report of four cases in young adults and plea for wider immunization.
    Bryan CS; Gregg AR
    J S C Med Assoc; 2011 Jun; 107(3):83-6. PubMed ID: 22057709
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic effectiveness of an inactivated formol influenza vaccine].
    Agafonov VI; Perepelkin VS; Chemeris EA; Novikov NL
    Voen Med Zh; 1981 Feb; (2):36-8. PubMed ID: 7233843
    [No Abstract]   [Full Text] [Related]  

  • 7. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.
    Wesley RD; Tang M; Lager KM
    Vaccine; 2004 Sep; 22(25-26):3427-34. PubMed ID: 15308368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).
    Tang M; Harp JA; Wesley RD
    Arch Virol; 2002 Nov; 147(11):2125-41. PubMed ID: 12417948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Advisory Committee on Immunization (NACI) statement on influenza vaccination for the 1995-96 season.
    Can Commun Dis Rep; 1995 Jun; 21(12):105-13. PubMed ID: 7647747
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the immunity to A/swine influenza virus in a sample of population of Rome].
    Volpi A; Conte A
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):284-6. PubMed ID: 1016580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of acute respiratory disease in the community of Port Chalmers. III. Efficacy of influenza virus subunit vaccines in 1973, 1974 and 1975.
    Jennings LC; MacDiarmid RD; Miles JA
    N Z Med J; 1980 Sep; 92(668):230-3. PubMed ID: 6935541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 15. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1992-93 season.
    Can Commun Dis Rep; 1992 May; 18(10):73-8. PubMed ID: 1284383
    [No Abstract]   [Full Text] [Related]  

  • 17. [Field trial with a new type of influenza subunit vaccine (author's transl)].
    Kunz C; Hofmann H
    Wien Klin Wochenschr; 1976 Aug; 88(15):504-8. PubMed ID: 997532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral influenza vaccination with live attenuated viruses. 2. Protective efficacy during a type A(H3N2) epidemic.
    Petrilli FL; Crovari P; Cuneo-Crovari P; Badolati G; Canepa R
    Boll Ist Sieroter Milan; 1975 Oct; 54(4):323-30. PubMed ID: 1203088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain-specificity of antibody to haemagglutinin following inactivated A/port chalmers/1/73 vaccine in man: evidence for a paradoxical strain-specific antibody response.
    Schild GC; Smith JW; Cretescu L; Newman RW; Wood JM
    Dev Biol Stand; 1977 Jun 1-3; 39():273-81. PubMed ID: 604109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
    J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.